RUSAL (00486): The court rejected Sual's application to convene a special general meeting of the company's shareholders.

06/04/2025

GMT Eight

RUSAL (00486) announced that, as disclosed in previous announcements, in November 2024, the company's major shareholder "SUAL Partners" ILLC (Sual) initiated arbitration proceedings against the company in the Kaliningrad Regional Arbitration Court, seeking confirmation that the resolution of the company's board of directors regarding the holding of a special shareholders' meeting is invalid. The Kaliningrad Regional Arbitration Court ruled on April 2, 2025, dismissing Sual's application to convene a special shareholders' meeting.

PEIJIA-B(09996): ReachTactile Siasun Robot & Automation assisted TAVR system successfully completed the first patient treatment.

GCL TECH(03800)The EBITDA for the first quarter of the photovoltaic materials business segment is approximately 5.05 billion yuan.

Contact: [email protected]

RUSAL (00486): The court rejected Sual's application to convene a special general meeting of the company's shareholders.

RECOMMEND

10 new drugs of a certain type approved for clinical trials in China for the first time! From HANSOH PHARMA (03692) and others

The reasons behind the listing of Hengrong International (US.TOPW) in the United States: After 11 trading days, the cumulative decline exceeded 46%, is the luxury watch no longer popular?

In the field of self-immunity, there is hope for the continued development of multiple FIC therapies. These targets may give birth to the next "drug king."